Publications, Pharmaceutical

An Eye on the Future of Preservative-Free Drops

In this article, Alexandra Ritter, Head of Regulatory Affairs and Combination Products, and Matthias Birkhoff, Vice-President Business Development, both at Aptar Pharma, discuss the value that Aptar Pharma’s regulatory support and services add to the filing process of a new eye care development, the challenges of administering a wider range of medications via topical eye drops and the benefits of preservative-free multidose ophthalmic drug-device combination products.

For more information on ONdrugDelivery.

 

Download Publication
Author(s): Alexandra Ritter Matthias Birkhoff
15 Mar 2022

Learn more about Ophthalmic Squeeze Dispenser

Find Out More About OSD

This Might Also Be of Interest

1 Jan 2020

Aptar Pharma discusses tests for preservative-free, topical eye drops

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Product Solutions

Read More
1 Dec 2019

The Current State of Play in Connected Devices

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Product Solutions

Read More
3 Jun 2019

Microbial integrity testing for preservative-free drug formulations

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions

Read More
1 Jun 2018

Connected Medicine: Insights from Payers and Other Stakeholders

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Product Solutions

Read More
1 … 3 4 5 6

Request Access

Close

Requesting access to An Eye on the Future of Preservative-Free Drops.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is for validation purposes and should be left unchanged.

How Can We Help?

Back To Top